EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
Shunli Peng(Nanfang Hospital), Wei Wang(Southern Medical University)
Cited by 316
Related Papers
Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma
|Molecular Cancer Therapeutics|2014|83